These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28941610)

  • 41. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia.
    Ogura M; Hori M; Harada-Shiba M
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Premature coronary heart disease and autosomal dominant hypercholesterolemia: Increased risk in women with LDLR mutations.
    Ahmad Z; Li X; Wosik J; Mani P; Petr J; McLeod G; Murad S; Song L; Adams-Huet B; Garg A
    J Clin Lipidol; 2016; 10(1):101-8.e1-3. PubMed ID: 26892126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double mutant [N543H+2393del9] allele in the LDL receptor gene in familial hypercholesterolemia: effect on plasma cholesterol levels and cardiovascular disease.
    Castillo S; Reyes G; Tejedor D; Mozas P; Suarez Y; Lasuncion MA; Cenarro A; Civeira F; Alonso R; Mata P; Pocovi M;
    Hum Mutat; 2002 Dec; 20(6):477. PubMed ID: 12442279
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABCG8 gene polymorphisms, plasma cholesterol concentrations, and risk of cardiovascular disease in familial hypercholesterolemia.
    Koeijvoets KC; van der Net JB; Dallinga-Thie GM; Steyerberg EW; Mensink RP; Kastelein JJ; Sijbrands EJ; Plat J
    Atherosclerosis; 2009 Jun; 204(2):453-8. PubMed ID: 18977479
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors.
    Alonso R; Mata N; Castillo S; Fuentes F; Saenz P; Muñiz O; Galiana J; Figueras R; Diaz JL; Gomez-Enterría P; Mauri M; Piedecausa M; Irigoyen L; Aguado R; Mata P;
    Atherosclerosis; 2008 Oct; 200(2):315-21. PubMed ID: 18243212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations.
    Viladés Medel D; Leta Petracca R; Carreras Costa F; Cardona Olle M; Barros Membrilla A; Hidalgo Perez JA; Pujadas Olano S; Alomar Serrallach X; Franco Peral M; Pons-Lladó G
    Am J Cardiol; 2013 Apr; 111(7):955-61. PubMed ID: 23340035
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
    Benn M; Watts GF; Tybjaerg-Hansen A; Nordestgaard BG
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3956-64. PubMed ID: 22893714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia.
    Dedoussis GV; Maumus S; Skoumas J; Choumerianou DM; Pitsavos C; Stefanadis C; Visvikis-Siest S
    J Clin Lab Anal; 2006; 20(3):98-104. PubMed ID: 16721833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical characterization and mutation spectrum of German patients with familial hypercholesterolemia.
    Grenkowitz T; Kassner U; Wühle-Demuth M; Salewsky B; Rosada A; Zemojtel T; Hopfenmüller W; Isermann B; Borucki K; Heigl F; Laufs U; Wagner S; Kleber ME; Binner P; März W; Steinhagen-Thiessen E; Demuth I
    Atherosclerosis; 2016 Oct; 253():88-93. PubMed ID: 27596133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The management of familial hypercholesterolaemia in Morocco.
    El Messal M; Aït Chihab K; Chater R; Loutfi M; Kettani A; Hafidi A; Adlouni A
    Acta Cardiol; 2006 Oct; 61(5):551-5. PubMed ID: 17117756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations.
    Tada H; Kawashiri MA; Yoshida T; Teramoto R; Nohara A; Konno T; Inazu A; Mabuchi H; Yamagishi M; Hayashi K
    Circ J; 2016; 80(2):512-8. PubMed ID: 26632531
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
    Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
    Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
    Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
    Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessment.
    Ellis KL; Hooper AJ; Pang J; Chan DC; Burnett JR; Bell DA; Schultz CJ; Moses EK; Watts GF
    Clin Genet; 2020 Feb; 97(2):257-263. PubMed ID: 31571196
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia.
    Paquette M; Bernard S; Thanassoulis G; Baass A
    J Clin Lipidol; 2019; 13(4):627-633.e1. PubMed ID: 31103339
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia.
    Kawashiri M; Kajinami K; Nohara A; Yagi K; Inazu A; Koizumi J; Mabuchi H
    Am J Cardiol; 2000 Oct; 86(8):840-5. PubMed ID: 11024398
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of practical applicability and clinical relevance of a commonly used LDL-C polygenic score in patients with severe hypercholesterolemia.
    Tromp TR; Cupido AJ; Reeskamp LF; Stroes ESG; Hovingh GK; Defesche JC; Schmidt AF; Zuurbier L
    Atherosclerosis; 2022 Jan; 340():61-67. PubMed ID: 34774301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
    Khan SP; Ghani R; Ahmed KZ; Yaqoob Z
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
    BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between OLR1 K167N SNP and intima media thickness of the common carotid artery in the general population.
    Predazzi IM; Norata GD; Vecchione L; Garlaschelli K; Amati F; Grigore L; Cutuli L; Pirillo A; Tramontana S; Romeo F; Novelli G; Catapano AL
    PLoS One; 2012; 7(2):e31086. PubMed ID: 22347434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.